JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 173.85 Million | 145.7 Million | 30.79 Million | - | 5.48 Million | 215 Thousand |
| Cost of Revenue | 85.63 Million | 86.94 Million | 21.75 Million | - | - | - |
| Gross Profit | 88.21 Million | 58.75 Million | 9.04 Million | - | 5.48 Million | 215 Thousand |
| Operating Expenses | 877.82 Million | 755.07 Million | 780.2 Million | 468.45 Million | 203.51 Million | 117.03 Million |
| Selling, General and Administrative Expenses | 117.75 Million | 261.18 Million | 249.97 Million | 93.14 Million | 26.63 Million | 20.54 Million |
| Research and Development Expenses | 413.61 Million | 407.81 Million | 414.39 Million | 225.21 Million | 136.1 Million | 75.98 Million |
| Other Expenses | 346.45 Million | -853 Thousand | -678 Thousand | -1.19 Billion | -128.86 Million | -45.75 Million |
| Cost and Expenses | 963.46 Million | 842.02 Million | 801.95 Million | 468.45 Million | 203.51 Million | 117.03 Million |
| Operating Income | -789.6 Million | -855.88 Million | -759.08 Million | -440.83 Million | -204.68 Million | -112.23 Million |
| Interest Expense | 12.41 Million | 6.78 Million | 2.69 Million | 770 Thousand | 1.35 Million | 2.91 Million |
| Income Tax Expense | - | 16.7 Million | 10.38 Million | -1.18 Billion | -126.96 Million | -44.93 Million |
| Earnings before Tax | -767.99 Million | -846.13 Million | -702.32 Million | -1.66 Billion | -633.25 Million | -272.61 Million |
| Net Income | -767.99 Million | -846.13 Million | -702.32 Million | -1.66 Billion | -633.25 Million | -272.61 Million |
| Earnings Per Share Basic | -1.87 | -2.06 | -1.76 | -12.61 | -1.68 | -0.72 |
| Earnings Per Share Diluted | -1.87 | -2.06 | -1.76 | -12.61 | -1.68 | -0.72 |
| Weighted Average Shares Outstanding | 411.53 Million | 410.09 Million | 399.74 Million | 131.9 Million | 376.17 Million | 376.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 411.53 Million | 410.09 Million | 399.74 Million | 131.9 Million | 376.17 Million | 376.17 Million |
| Gross Margin | 0.51 | 0.40 | 0.29 | - | 1.00 | 1.00 |
| EBIT Margin | -3.77 | -5.16 | -22.74 | - | -57.33 | -707.25 |
| Profit Margin | -4.42 | -5.81 | -22.81 | - | -115.49 | -1267.98 |
| EBITDA | -655.74 Million | -752.27 Million | -700.47 Million | -1.6 Billion | -314.33 Million | -152.05 Million |
| Earnings Before Tax Margin | -4.54 | -5.87 | -24.65 | - | -37.33 | -522.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.97 Million | 6.01 Million | 173.85 Million | 11.91 Million | 5.89 Million | 12.65 Million |
| Cost of Revenue | 2.96 Million | 2.98 Million | 85.63 Million | 11.14 Million | 2.92 Million | 11.53 Million |
| Gross Profit | 3 Million | 3.02 Million | 88.21 Million | 766.68 Thousand | 2.97 Million | 1.12 Million |
| Operating Expenses | 20.03 Million | 20.16 Million | 658.61 Million | 37.84 Million | 30.34 Million | 45.93 Million |
| Selling, General and Administrative Expenses | 9.31 Million | 9.37 Million | - | 15.01 Million | 7.83 Million | 19.11 Million |
| Research and Development Expenses | 10.38 Million | 10.45 Million | - | 22.82 Million | 13.49 Million | 26.81 Million |
| Other Expenses | 333.33 Thousand | 335.5 Thousand | 246 Thousand | - | - | - |
| Cost and Expenses | 23 Million | 23.15 Million | 744.24 Million | 48.98 Million | 33.26 Million | 57.46 Million |
| Operating Income | -17.02 Million | -17.13 Million | -789.6 Million | -37.07 Million | -17.91 Million | -44.8 Million |
| Interest Expense | 839.77 Thousand | - | 12.41 Million | 944.97 Thousand | - | 805.49 Thousand |
| Income Tax Expense | 481.46 Thousand | 484.59 Thousand | -3.29 Million | 1.00 | - | 1.00 |
| Earnings before Tax | -16.53 Million | -16.63 Million | -767.99 Million | -53.6 Million | -26.54 Million | -54.88 Million |
| Net Income | -16.53 Million | -16.63 Million | -767.99 Million | -53.6 Million | -26.54 Million | -54.88 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | - | -0.13 | -0.06 | -0.13 |
| Earnings Per Share Diluted | -0.04 | -0.04 | - | -0.13 | -0.06 | -0.13 |
| Weighted Average Shares Outstanding | 413.08 Million | 413.08 Million | 411.53 Million | 401.56 Million | 411.93 Million | 411.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 413.08 Million | 413.08 Million | 411.53 Million | 401.56 Million | 411.93 Million | 411.12 Million |
| Gross Margin | 0.50 | 0.50 | 0.51 | 0.06 | 0.50 | 0.09 |
| EBIT Margin | -2.36 | -2.36 | - | -2.54 | -2.62 | -2.99 |
| Profit Margin | -2.77 | -2.77 | -4.42 | -4.50 | -4.50 | -4.34 |
| EBITDA | -14.09 Million | -14.19 Million | - | -30.22 Million | -15.44 Million | -37.87 Million |
| Earnings Before Tax Margin | -2.85 | -2.85 | -4.54 | -3.11 | -3.04 | -3.54 |
GS-PD
AMIC
BYSD
PUCCF
2488
PDNLA